Corrigendum to “In-vitro activity of polyhexanide alone and in combination with antibiotics against Staphylococcus aureus” [J Hosp Infect 86 (2014) 68–72](S0195670113003654)(10.1016/j.jhin.2013.10.002);In-vitro activity of polyhexanide alone and in combination with antibiotics against Staphylococcus aureus

Journal of Hospital Infection

Volumn 86, Issue 1, 2014, Pages 68-72

  Fabry, W ^a   Kock, H J ^b  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b VIVANTES HOSPITAL   (Germany)

Author keywords

Antibiotic; Antiseptic; Meticillin resistant Staphylococcus aureus; Minimum bactericidal concentration; Minimum inhibitory concentration; Polyhexanide; Staphylococcus aureus

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFUROXIME; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; OXACILLIN; PENICILLIN G; POLYHEXANIDE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SCREENING; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS;

ANTIBIOTIC; ANTISEPTIC; METICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; POLYHEXANIDE; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; BIGUANIDES; DRUG SYNERGISM; ELECTROPHORESIS, GEL, PULSED-FIELD; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; STAPHYLOCOCCUS AUREUS;

EID: 84890559363     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2017.09.005     Document Type: Erratum

References (33)

1. Lowy F.D. Staphylococcus aureus infections. NEngl J Med 1998, 339:520-532.
2. Kluytmans J., van Belkum A., Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997, 10:505-520.
3. von Eif C., Becker K., Machka K., Stammer H., Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. NEngl J Med 2001, 344:11-16.
4. Harbarth S., Dharan S., Liassine N., Herrault P., Auckenthaler R., Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999, 43:1412-1416.
5. Jones J.C., Rogers T.J., Brookmeyer P., et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007, 45:541-547.
6. Patel J.B., Gorwitz R.J., Jernigan J.A. Mupirocin resistance. Clin Infect Dis 2009, 49:935-941.
7. Brumfitt W., Dixson S., Hamilton-Miller J.M.T. Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus. Lancet 1985, 1:1442-1443.
8. Suller M.T.E., Russell A.D. Triclosan and antibiotic resistance in Staphylococcus aureus. JAntimicrob Chemother 2000, 54:11-18.
9. Kallenberger A., Kallenberger C., Willenegger H. Experimental investigations on tissue compatibility of antiseptics. Hygiene Medizin 1991, 16:383-395.
10. ® and selected antiseptic agents. Hygiene Medizin 1993, 18:9-16.
11. Kramer A., Adrian V., Rudolph P., Wurster S., Lippert H. Explantationstest mit Haut und Peritoneum der neonatalen Ratte als Voraussagetest zur Verträglichkeit lokaler Antiinfektiva für Wunden und Körperhöhlen. Chirurg 1998, 69:840-845.
12. Werner H.P. Microbicidal effectiveness of selected antiseptics. Hygiene Medizin 1992, 17:51-59.
13. Skripitz R., Werner H.P. Bactericidal long-term-effect of selective antiseptics. Hygiene Medizin 1994, 19:199-204.
14. Koburger T., Huebner N.O., Braun M., Siebert J., Kramer A. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. JAntimicrob Chemother 2010, 65:1712-1719.
15. Schmit-Neuerburg K., Bettag C., Schlickewei W., et al. Wirksamkeit eines neuartigen Antisepticum in der Behandlung kontaminierter Weichteilwunden. Chirurg 2001, 72:61-71.
16. Fabry W., Trampenau C., Bettag A.E., et al. Bacterial decontamination of surgical wounds treated with Lavasept. Int J Hyg Environ Health 2006, 209:567-573.
17. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual 1989, 6.50-6.62. Cold Spring Harbour Laboratory Press, Cold Spring Harbour. 2nd ed.
18. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. JClin Microbiol 1995, 33:2233-2239.
19. Deutsches Institut für Normung DIN 58940-8: medical microbiology - susceptibility testing of microbial pathogens to antimicrobial agents. Part 8: microdilution method; general methodic-specific requirements 2002, Beuth Verlag, Berlin.
20. Deutsches Institut für Normung DIN 58940-7: medical microbiology - susceptibility testing of microbial pathogens to antimicrobial agents. Part 7: determination of minimum bactericidal concentration with the method of microbouillondilution 2008, Beuth Verlag, Berlin.
21. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 3.0 2013, European Society of Clinical Microbiology and Infectious Diseases, Basel, Switzerland.
22. Moody J. Synergism testing: broth microdilution checkerboard and broth macrodilution methods. Clinical microbiology procedures handbook 2004, Vol. 2:5.12.1-5.12.23. ASM Press, Washington. 2nd ed.
23. Pillai S., Moellering R.C., Eliopoulos G. Antimicrobial combinations. Antibiotics in laboratory medicine 2005, 365-440. Lippincott Williams & Wilkins, Baltimore. 5th ed. V. Lorian (Ed.).
24. Seipp H.M., Stroh A. Methicillin-resistente S.aureus (MRSA) - signifikante Reduktion von Inzidenz und Rate in einem Klinikum der Maximalversorgung (1994 bis 1999). Hygiene Medizin 1999, 24:224-237.
25. Rietkötter J., Körber A., Grabbe S., Dissemond J. Eradication of methicillin-resistant Staphylococcus aureus in a chronic wound by a new polyhexanide hydrogel. JEur Acad Dermatol Venereol 2007, 21:1416-1417.
26. Ansorg R., Azem T., Fabry W.H., Rath P.M. Influence of mucin on the activity of the antiseptic Lavasept against Staphylococcus aureus. Chemotherapy 2002, 48:129-133.
27. Ansorg R., Rath P.M., Fabry W. Inhibition of the anti-staphylococcal activity of the antiseptic polyhexanide by mucin. Arzneim-Forsch/Drug Res 2003, 53:368-371.
28. Deutsches Institut für Normung DIN EN 1040: chemical disinfectants and antiseptics - quantitative suspension test for the evaluation of basic bactericidal activity of chemical disinfectants and antiseptics - test method and requirements (phase 1) 2005, Beuth Verlag, Berlin.
29. Seipp H.M., Stroh A. Multiresistant Staphylococcus aureus. Part 3: decontamination and prevention of recontamination. Hygiene Medizin 1997, 22:285-305.
30. Kramer A., Roth B., Müller G., Rudolph P., Klöcker N. Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol 2004, 17:141-146.
31. Mueller G., Kramer A. Biocompatibility index of antiseptic agents by parallel assessment of antimicrobial activity and cellular cytotoxicity. JAntimicrob Chemother 2008, 61:1281-1287.
32. Rotter M. Staphylokokken und Desinfektion. Chemother J 2009, 18:89-92.
33. Lipinsky B.A., Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin Infect Dis 2009, 49:1541-1549.